glp 1 psoriasis GLP-1 drugs Ozempic, Zepbound, and Mounjaro for and Psoriatic Arthritis Which PsO Patients Can Benefit

G.ZhangY

In December 2025, Eli Lilly announced positive topline results from TRIUMPH-4 a 68-week Phase 3 trial in adults with obesity and knee osteoarthritis in which retatrutide delivered average weight loss of up to 71.2 lbs alongside substantial reductions in osteoarthritis pain

Membrane bound Kit ligand regulates melanocyte adhesion and survival, providing physical interaction with an intraepithelial niche

Tirzepatides dual mechanism distinguishes it from earlier GLP-1 therapies

Developed and maintained by DagangAsia Network Holding Sdn

Reliability to operate Create certainty and peace of mind for operators, production managers, and management with transparent information available to all